J&J Hears Consent Decree Echoes In Litigation From ‘Silent’ Motrin Recall
This article was originally published in The Tan Sheet
J&J intends to appeal to Oregon’s Supreme Court the state appellate court’s decision that the absence of proof of harm to consumers from sales of Motrin 200mg that failed to meet dissolution standards does not preclude unfair trade litigation filed by the state attorney general.
You may also be interested in...
A key House committee chairman questions why FDA has not inspected McNeil Consumer Healthcare's Puerto Rico plant despite a requirement that the Johnson & Johnson business pay the agency's costs.
Johnson & Johnson failed to provide proof that FDA acknowledged the firm's plan for a "phantom" recall of a Motrin product, according to Capitol Hill staff
Reps. Brendan Boyle and Darin LaHood introduce Dietary Supplement Tax Fairness Ac to amend Internal Revenue Code to include some supplement products as qualified medical expenses.